Is Sonic Healthcare (SHL) Halal?

ASX Healthcare Australia $10.2B
✗ NOT HALAL
Confidence: 90/100
Sonic Healthcare (SHL) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 45.9% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. Sonic Healthcare operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from June 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 45.9%
/ 30%
6.0%
/ 30%
13.3%
/ 30%
0.23%
/ 5%
✗ NOT HALAL
DJIM 45.9%
/ 33%
6.0%
/ 33%
13.3%
/ 33%
0.23%
/ 5%
✗ NOT HALAL
MSCI 32.2%
/ 33%
4.2%
/ 33%
9.4%
/ 33%
0.23%
/ 5%
✓ HALAL
S&P 45.9%
/ 33%
6.0%
/ 33%
13.3%
/ 33%
0.23%
/ 5%
✗ NOT HALAL
FTSE 32.2%
/ 33%
4.2%
/ 33%
9.4%
/ 50%
0.23%
/ 5%
✓ HALAL

Financial Highlights

P/E Ratio
18.6
Forward: 15.3
EPS
$1.11
Dividend Yield
524.0%
Payout: 96.8%
P/B Ratio
1.2
EV/EBITDA
11.9
EV: $15.7B
Revenue
$9.6B
Growth: 16.6%
Beta
0.5
Low volatility
Current Ratio
1.0

Profitability

Gross Margin 32.8%
Operating Margin 9.0%
Net Margin 5.2%
Return on Equity (ROE) 6.6%
Return on Assets (ROA) 3.8%

Cash Flow & Balance Sheet

Free Cash Flow$834M
Total Debt$5.2B
Debt-to-Equity68.2
Current Ratio1.0
Total Assets$16.1B

Price & Trading

Last CloseAUD 20.38
50-Day MAAUD 22.17
200-Day MAAUD 23.39
Avg Volume1.5M
Beta0.5
52-Week Range
AUD 19.57
AUD 29.24

About Sonic Healthcare (SHL)

CEO
Dr. James Pacey Newcombe
Employees
45,000
Sector
Healthcare
Industry
Diagnostics & Research
Country
Australia
Exchange
ASX
Market Cap
$10.2B
Currency
AUD

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Sonic Healthcare (SHL) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Sonic Healthcare is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Sonic Healthcare's debt ratio?

Sonic Healthcare's debt ratio is 45.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 32.2%.

What are Sonic Healthcare's key financial metrics?

Sonic Healthcare has a market capitalization of $10.2B, trailing P/E ratio of 18.6, and revenue of $9.6B. The company maintains a gross margin of 32.8% and a net margin of 5.2%. Return on equity stands at 6.6%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.